Evidence map›Paper›PMID 39193540›Full record

ArticleJournal of market access & health policy2024

Adoption of a Societal Perspective in Economic Evaluations of Musculoskeletal Disorders: A Conceptual Paper.

Francis Fatoye, Tadesse Gebrye, Leo Nherera, Paul Trueman

Abstract read
In one paragraph

Article in Journal of market access & health policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Francis FatoyeDepartment of Health Professions, Faculty of Health and Education, Brooks Building I Manchester Metropolitan University, Manchester M15 6GX, UK; t.gebrye@mmu.ac.uk.
Tadesse GebryeDepartment of Health Professions, Faculty of Health and Education, Brooks Building I Manchester Metropolitan University, Manchester M15 6GX, UK; t.gebrye@mmu.ac.uk.ORCID https://orcid.org/0000-0001-7976-2013
Leo NhereraSmith + Nephew Inc., Global Market Access, 5600 Clearfork Main St, Fort Worth, TX 76109, USA; leo.nherera@smith-nephew.com (L.N.); paul.trueman@smith-nephew.com (P.T.).ORCID https://orcid.org/0000-0003-1758-9504
Paul TruemanSmith + Nephew Inc., Global Market Access, 5600 Clearfork Main St, Fort Worth, TX 76109, USA; leo.nherera@smith-nephew.com (L.N.); paul.trueman@smith-nephew.com (P.T.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Economic evaluations are used to compare the costs and consequences of healthcare interventions, including those for musculoskeletal (MSK) disorders, which are very common and a major source of morbidity and absence from work. Reimbursement decisions for interventions for MSK disorders by decision-makers rely on the findings of economic evaluations, the design and results of which depend largely on the perspective adopted. Despite methodological advancements in economic evaluations, there are no clear guidelines on the perspective to adopt. This paper explores the adoption of a societal perspective in economic evaluations of MSK disorders. Within health economics evaluations, the most commonly used perspectives include the payer perspective, the healthcare perspective, and the societal perspective. To facilitate optimal resource allocation decisions in order to reduce the significant economic burden of MSK disorders and improve the health outcomes of individuals with these disorders, all costs and benefits associated with interventions for them should be included. Thus, the societal perspective is arguably a preferable option to the others for economic evaluations of interventions for MSK disorders.

Indexed as

economic evaluationhealth economicperspectivesocietal perspective

Identifiers

PMID39193540
PMCPMC11348208

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.